2026 Nobel Prize in Medicine Awarded for Pioneering Optogenetics Research
Karl Deisseroth, Peter Hegemann, and Georg Nagel have won the 2026 Nobel Prize in Medicine for pioneering optogenetics, transforming neuroscience and clinical medicine with light-controlled neural activation.
- • Karl Deisseroth, Peter Hegemann, and Georg Nagel awarded the 2026 Nobel Prize in Physiology or Medicine for optogenetics.
- • They discovered and utilized light-sensitive proteins to control nerve cells and study brain functions related to memory, behavior, and psychiatric disorders.
- • Optogenetics has advanced understanding of neural circuits and is used clinically, including efforts to restore vision in blind patients.
- • The total prize money is 12 million Swedish kronor, to be equally shared among the three laureates, with the ceremony set for December 10, 2026.
Key details
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their groundbreaking discoveries in optogenetics, a technique that uses light-sensitive proteins to control nerve cells in the brain. This innovative approach has significantly advanced the understanding of how nerve cells form memories, emotions, and behaviors.
Peter Hegemann and Georg Nagel first discovered channelrhodopsin, a light-sensitive protein found in single-celled algae. They successfully introduced the gene for this protein into other cells, making them responsive to light. Building on this foundation, Karl Deisseroth transformed this discovery into optogenetics, a method that allows precise manipulation of neural circuits using light. Deisseroth's interest in the field was influenced by his medical studies, where he encountered patients with mental health disorders and sought to uncover the neural mechanisms behind these conditions.
Optogenetics has revolutionized neuroscience by enabling researchers to pinpoint which neural circuits are involved in specific behaviors and psychiatric disorders such as depression, anxiety, and schizophrenia. It has also expanded knowledge around pain perception, social behavior, and thirst. Beyond basic research, optogenetics is being employed clinically to explore therapeutic possibilities, including efforts to restore vision in blind patients.
The Nobel Assembly at the Karolinska Institute announced the prize, noting the transformative impact of these discoveries on neuroscience. The award ceremony will be held in Stockholm on December 10, 2026. This year's Nobel Prize will distribute a total of 12 million Swedish kronor equally among the three laureates, an increase by one million kronor compared to previous years.
According to the Nobel Committee, "Their research has laid the foundation for a new era in neuroscience, enabling scientists to research neural circuits with unprecedented precision, which is critical for understanding brain function and neurological disorders."
This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.
Source articles (3)
Source comparison
Latest news
Psychologist Highlights Nostalgia's Role in Easing Stress and Anxiety
2026 Nobel Prize in Medicine Awarded for Pioneering Optogenetics Research
Sweden Leads Nations League Group as They Prepare to Face Struggling Romania
Coop Slashes Prices on Over 600 Products to Challenge High-Cost Image
Warning Signs Point to Upcoming Food Price Increases in Sweden
Sweden's 2026 Government Formation Hits Roadblocks as Leaders Seek New Paths
The top news stories in Sweden
Delivered straight to your inbox each morning.